Cargando…

Synergy between Auranofin and Celecoxib against Colon Cancer In Vitro and In Vivo through a Novel Redox-Mediated Mechanism

Recent study suggests that auranofin (AF), a US Food and Drug Administration (FDA)-approved drug for treatment of rheumatoid arthritis, has selective anticancer activity in various experimental models. Its clinical applications in cancer treatment, however, have been hampered due in part to its rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Yi, Chen, Ping, Zhang, Yanyu, Lu, Wenhua, Ding, Wenwen, Luo, Yao, Wen, Shijun, Xu, Ruihua, Liu, Panpan, Huang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678510/ https://www.ncbi.nlm.nih.gov/pubmed/31277230 http://dx.doi.org/10.3390/cancers11070931

Ejemplares similares

Auranofin induces urothelial carcinoma cell death via reactive oxygen species production and synergy with cisplatin
por: Chen, San-Yuan, et al.
Publicado: (2022)

Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo
por: He, Jiayang, et al.
Publicado: (2018)

Comprehensive chemical proteomics for target deconvolution of the redox active drug auranofin
por: Saei, Amir Ata, et al.
Publicado: (2020)

Auranofin Is Highly Efficacious against Toxoplasma gondii In Vitro and in an In Vivo Experimental Model of Acute Toxoplasmosis
por: Andrade, Rosa M., et al.
Publicado: (2014)

Mitochondrial TXNRD3 confers drug resistance via redox-mediated mechanism and is a potential therapeutic target in vivo
por: Liu, Xiaoxia, et al.
Publicado: (2020)

Redox proteome analysis of auranofin exposed ovarian cancer cells (A2780)
por: Chiappetta, Giovanni, et al.
Publicado: (2022)

Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells
por: Sachweh, Marijke C.C., et al.
Publicado: (2015)

TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole
por: Oberstadt, Moritz, et al.
Publicado: (2018)

Novel Insights into Redox-Based Mechanisms for Auranofin-Induced Rapid Cancer Cell Death
por: Hatem, Elie, et al.
Publicado: (2022)

In vitro antineoplastic effects of auranofin in canine lymphoma cells
por: Zhang, Hong, et al.
Publicado: (2018)

Cyclic Voltammetry of Auranofin
por: Mohamed, Ahmed A., et al.
Publicado: (1999)

Combination of Auranofin and ICG-001 Suppress the Proliferation and Metastasis of Colon Cancer
por: Lin, Zhaoyan, et al.
Publicado: (2021)

Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation
por: Begum, M. Yasmin, et al.
Publicado: (2022)

In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection
por: Roder, Christine, et al.
Publicado: (2020)

In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection
por: Abutaleb, Nader S., et al.
Publicado: (2021)

In Vitro Activity of Auranofin in Combination With Aztreonam-Avibactam Against Metallo-β-lactamase (MBL)-Producing Enterobacterales
por: Wang, Wen, et al.
Publicado: (2021)

Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death
por: Habermann, Karoline Johanna, et al.
Publicado: (2017)

CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide
por: Kast, Richard E., et al.
Publicado: (2014)

Efficacy of auranofin as an inhibitor of desmoid progression
por: Ito, Kan, et al.
Publicado: (2022)

Celecoxib increases retinoid sensitivity in human colon cancer cell lines
por: Liu, Jian-Pei, et al.
Publicado: (2010)

Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
por: Dai, Zhi-Jun, et al.
Publicado: (2012)

Celecoxib suppresses lipopolysaccharide-stimulated oral squamous cell carcinoma proliferation in vitro and in vivo
por: Yoshida, Hisato, et al.
Publicado: (2019)

Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo
por: Fan, C, et al.
Publicado: (2014)

Auranofin is a potent suppressor of osteosarcoma metastasis
por: Topkas, Eleni, et al.
Publicado: (2015)

Evaluation of Auranofin Loading within Ferritin Nanocages
por: Lucignano, Rosanna, et al.
Publicado: (2022)

The Kinetics and Mechanism of the Reaction Between Serum Albumin and Auranofin (and its Isopropyl Analogue) In Vitro
por: Roberts, Jacqueline R., et al.
Publicado: (1994)

Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo
por: Pyrko, Peter, et al.
Publicado: (2006)

Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo
por: Huang, Hongbiao, et al.
Publicado: (2015)

Effect of Deep Eutectic System (DES) on Oral Bioavailability of Celecoxib: In Silico, In Vitro, and In Vivo Study
por: Chakraborty, Soumalya, et al.
Publicado: (2023)

Will Auranofin Become a Golden New Treatment Against COVID-19?
por: Sonzogni-Desautels, Karine, et al.
Publicado: (2021)

New Auranofin Analogs with Antibacterial Properties against Burkholderia Clinical Isolates
por: Maydaniuk, Dustin, et al.
Publicado: (2021)

Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis
por: Hou, Guo-Xin, et al.
Publicado: (2018)

Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro
por: Hwangbo, Hyun, et al.
Publicado: (2020)

Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020)

Celecoxib-Loaded Solid Lipid Nanoparticles for Colon Delivery: Formulation Optimization and In Vitro Assessment of Anti-Cancer Activity
por: Alajami, Hamdan N., et al.
Publicado: (2022)

Riboceine Rescues Auranofin-Induced Craniofacial Defects in Zebrafish
por: Leask, Megan, et al.
Publicado: (2021)

The gold complex auranofin: new perspectives for cancer therapy
por: Abdalbari, Farah H., et al.
Publicado: (2021)

Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer
por: Steers, Garett J., et al.
Publicado: (2022)

Menadione Potentiates Auranofin-Induced Glioblastoma Cell Death
por: Szeliga, Monika, et al.
Publicado: (2022)

Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin
por: Kim, Hyun Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qbplpnat8la5sce3pivu64m1v5